Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017162615> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W2017162615 endingPage "363" @default.
- W2017162615 startingPage "357" @default.
- W2017162615 abstract "To compare the complication rate and effectiveness of mitomycin C (MMC), Ologen alone, and Ologen with 5-fluorouracil (5-FU) as adjunctives with Ex-PRESS mini shunt for medically uncontrolled glaucoma. Retrospective comparative study of 59 Ex-PRESS mini shunt trabeculectomy operations coupled with Ologen implantation alone, transient MMC application or Ologen implantation with 5-FU as adjunctive treatment. Eight eyes (7 patients) received Ologen alone, 37 eyes (34 patients) received MMC, and 14 eyes (14 patients) received Ologen with 5-FU as adjunctive therapy. Baseline characteristics, adjunctive used during operation, along with outcomes including intraocular pressure (IOP), number of anti-hypertensive drops, visual acuity, and complications were documented and compared. The primary outcome was IOP at 12 months. Variables were compared with r × c Fisher tests. The Ologen only group had a significantly higher IOP at 12 months (20.5 ± 10.23 mmHg) compared with Ologen combined with 5-FU (12.2 ± 1.47 mmHg) or MMC (13.8 ± 4.37 mmHg) (p = 0.015, linear mixed model). The Ologen only cohort also had a higher re-operation rate (p = 0.01, Fisher’s Exact Test) and higher rate of bleb leak (p = 0.02, Fisher’s Exact Test). Visual acuity was similar among all three groups. 5-FU with Ologen is as effective as MMC in maintaining IOP following Ex-PRESS shunt surgery at 1 year. However, Ologen alone may not be as effective as the other two adjunctive agents." @default.
- W2017162615 created "2016-06-24" @default.
- W2017162615 creator A5007927256 @default.
- W2017162615 creator A5011959510 @default.
- W2017162615 creator A5042926980 @default.
- W2017162615 creator A5062273688 @default.
- W2017162615 creator A5069369290 @default.
- W2017162615 creator A5075981090 @default.
- W2017162615 date "2014-06-12" @default.
- W2017162615 modified "2023-09-26" @default.
- W2017162615 title "Ex-PRESS outcomes using mitomycin-C, Ologen alone, Ologen with 5-fluorouracil" @default.
- W2017162615 cites W118667476 @default.
- W2017162615 cites W1608938923 @default.
- W2017162615 cites W1851990076 @default.
- W2017162615 cites W1965953060 @default.
- W2017162615 cites W1996417275 @default.
- W2017162615 cites W2003364420 @default.
- W2017162615 cites W2011147094 @default.
- W2017162615 cites W2013130660 @default.
- W2017162615 cites W2027918204 @default.
- W2017162615 cites W2039252386 @default.
- W2017162615 cites W2054655846 @default.
- W2017162615 cites W2054821140 @default.
- W2017162615 cites W2059358526 @default.
- W2017162615 cites W2085415170 @default.
- W2017162615 cites W2091701340 @default.
- W2017162615 cites W2126905998 @default.
- W2017162615 doi "https://doi.org/10.1007/s10792-014-9955-3" @default.
- W2017162615 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24920197" @default.
- W2017162615 hasPublicationYear "2014" @default.
- W2017162615 type Work @default.
- W2017162615 sameAs 2017162615 @default.
- W2017162615 citedByCount "8" @default.
- W2017162615 countsByYear W20171626152015 @default.
- W2017162615 countsByYear W20171626152016 @default.
- W2017162615 countsByYear W20171626152017 @default.
- W2017162615 countsByYear W20171626152018 @default.
- W2017162615 countsByYear W20171626152019 @default.
- W2017162615 countsByYear W20171626152020 @default.
- W2017162615 countsByYear W20171626152023 @default.
- W2017162615 crossrefType "journal-article" @default.
- W2017162615 hasAuthorship W2017162615A5007927256 @default.
- W2017162615 hasAuthorship W2017162615A5011959510 @default.
- W2017162615 hasAuthorship W2017162615A5042926980 @default.
- W2017162615 hasAuthorship W2017162615A5062273688 @default.
- W2017162615 hasAuthorship W2017162615A5069369290 @default.
- W2017162615 hasAuthorship W2017162615A5075981090 @default.
- W2017162615 hasBestOaLocation W20171626152 @default.
- W2017162615 hasConcept C118487528 @default.
- W2017162615 hasConcept C141071460 @default.
- W2017162615 hasConcept C191093355 @default.
- W2017162615 hasConcept C2778527774 @default.
- W2017162615 hasConcept C2779338040 @default.
- W2017162615 hasConcept C2781092963 @default.
- W2017162615 hasConcept C71924100 @default.
- W2017162615 hasConceptScore W2017162615C118487528 @default.
- W2017162615 hasConceptScore W2017162615C141071460 @default.
- W2017162615 hasConceptScore W2017162615C191093355 @default.
- W2017162615 hasConceptScore W2017162615C2778527774 @default.
- W2017162615 hasConceptScore W2017162615C2779338040 @default.
- W2017162615 hasConceptScore W2017162615C2781092963 @default.
- W2017162615 hasConceptScore W2017162615C71924100 @default.
- W2017162615 hasIssue "3" @default.
- W2017162615 hasLocation W20171626151 @default.
- W2017162615 hasLocation W20171626152 @default.
- W2017162615 hasLocation W20171626153 @default.
- W2017162615 hasOpenAccess W2017162615 @default.
- W2017162615 hasPrimaryLocation W20171626151 @default.
- W2017162615 hasRelatedWork W1971004186 @default.
- W2017162615 hasRelatedWork W1988712767 @default.
- W2017162615 hasRelatedWork W1999486154 @default.
- W2017162615 hasRelatedWork W2022174493 @default.
- W2017162615 hasRelatedWork W2042967592 @default.
- W2017162615 hasRelatedWork W2062557057 @default.
- W2017162615 hasRelatedWork W2081801020 @default.
- W2017162615 hasRelatedWork W2347370477 @default.
- W2017162615 hasRelatedWork W4234120199 @default.
- W2017162615 hasRelatedWork W642445530 @default.
- W2017162615 hasVolume "35" @default.
- W2017162615 isParatext "false" @default.
- W2017162615 isRetracted "false" @default.
- W2017162615 magId "2017162615" @default.
- W2017162615 workType "article" @default.